Loss of breast epithelial marker hCLCA2 promotes epithelial to mesenchymal transition and indicates higher risk of metastasis

Transition between epithelial and mesenchymal states is a feature of both normal development and tumor progression. We report that expression of chloride channel accessory protein hCLCA2 is a characteristic of epithelial differentiation in the immortalized MCF10A and HMLE models, while induction of epithelial-to-mesenchymal transition by cell dilution, TGFβ or mesenchymal transcription factors sharply reduces hCLCA2 levels. Attenuation of hCLCA2 expression by lentiviral small hairpin RNA caused cell overgrowth and focus formation, enhanced migration and invasion, and increased mammosphere formation in methylcellulose. These changes were accompanied by downregulation of E-cadherin and upregulation of mesenchymal markers such as vimentin and fibronectin. Moreover, hCLCA2 expression is greatly downregulated in breast cancer cells with a mesenchymal or claudin-low profile. These observations suggest that loss of hCLCA2 may promote metastasis. We find that higher-than-median expression of hCLCA2 is associated with a one-third lower rate of metastasis over an 18-year period among breast cancer patients compared with lower-than-median (n=344, unfiltered for subtype). Thus, hCLCA2 is required for epithelial differentiation, and its loss during tumor progression contributes to metastasis. Overexpression of hCLCA2 has been reported to inhibit cell proliferation and is accompanied by increases in chloride current at the plasma membrane and reduced intracellular pH (pHi). We found that knockdown cells have sharply reduced chloride current and higher pHi, both characteristics of tumor cells. These results suggest a mechanism for the effects on differentiation. Loss of hCLCA2 may allow escape from pHi homeostatic mechanisms, permitting the higher intracellular and lower extracellular pH that are characteristic of aggressive tumor cells.

[1]  C. V. Jongeneel,et al.  Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data , 2006, Breast Cancer Research.

[2]  R. Elble,et al.  Enrichment for breast cancer cells with stem/progenitor properties by differential adhesion. , 2010, Stem cells and development.

[3]  J. McDougall,et al.  Production of spindle cell carcinoma by transduction of H-Ras 61L into immortalized human mammary epithelial cells. , 2003, Cancer letters.

[4]  Jason I. Herschkowitz,et al.  Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer , 2010, Breast Cancer Research.

[5]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[6]  H. Sontheimer.  An Unexpected Role for Ion Channels in Brain Tumor Metastasis , 2008, Experimental biology and medicine.

[7]  F Gambale,et al.  Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.

[8]  F. Bertucci,et al.  Gene expression profiling of breast cell lines identifies potential new basal markers , 2006, Oncogene.

[9]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[10]  R. Shirkoohi,et al.  siRNA gelsolin knockdown induces epithelial‐mesenchymal transition with a cadherin switch in human mammary epithelial cells , 2006, International journal of cancer.

[11]  W. Hahn,et al.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. , 2001, Genes & development.

[12]  C Caldas,et al.  Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis , 1999, British Journal of Cancer.

[13]  J. Ingle,et al.  Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts. , 2010, International journal of oncology.

[14]  T. Machen,et al.  Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[16]  W. Hahn,et al.  Identification of PP2A complexes and pathways involved in cell transformation. , 2010, Cancer research.

[17]  L. Counillon,et al.  CFTR modulates programmed cell death by decreasing intracellular pH in Chinese hamster lung fibroblasts. , 2001, American journal of physiology. Cell physiology.

[18]  R. Weinberg,et al.  Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. , 2007, Cancer research.

[19]  M. Sartor,et al.  In vitro multipotent differentiation and barrier function of a human mammary epithelium , 2009, Cell and Tissue Research.

[20]  V. Rotter,et al.  Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells , 2011, Cell Death and Differentiation.

[21]  P. Porter,et al.  Cytogenetic characterization and H-ras associated transformation of immortalized human mammary epithelial cells , 2006, Cancer Cell International.

[22]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[23]  L. Fliegel,et al.  Mitogen-activated Protein Kinase-dependent Activation of the Na+/H+ Exchanger Is Mediated through Phosphorylation of Amino Acids Ser770 and Ser771* , 2007, Journal of Biological Chemistry.

[24]  Jason I. Herschkowitz,et al.  Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. , 2010, The Journal of clinical investigation.

[25]  A. Gruber,et al.  The Putative Chloride Channel hCLCA2 Has a Single C-terminal Transmembrane Segment* , 2006, Journal of Biological Chemistry.

[26]  M. Tang,et al.  KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition. , 2007, Cancer research.

[27]  K. Kunzelmann.  Ion Channels and Cancer , 2005, The Journal of Membrane Biology.

[28]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[29]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[30]  A. Eastman,et al.  Endonuclease activation during apoptosis: the role of cytosolic Ca2+ and pH. , 1992, Biochemical and biophysical research communications.

[31]  M. Hamann,et al.  Human ClCa1 modulates anionic conduction of calcium-dependent chloride currents , 2009, The Journal of physiology.

[32]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[33]  Sumit Kumar,et al.  hCLCA2 Is a p53-Inducible Inhibitor of Breast Cancer Cell Proliferation. , 2009, Cancer research.

[34]  S. Lowe,et al.  Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Nicholas J. Wang,et al.  Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. , 2009, Cancer research.

[36]  K. Polyak,et al.  Psoriasin expression in mammary epithelial cells in vitro and in vivo. , 2002, Cancer research.

[37]  A. Gruber,et al.  Tumorigenicity of human breast cancer is associated with loss of the Ca2+-activated chloride channel CLCA2. , 1999, Cancer research.

[38]  John P. Moore,et al.  A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cells , 1985, Nature.

[39]  M. Collins,et al.  Intracellular acidification induces apoptosis by stimulating ICE-like protease activity. , 1997, Journal of cell science.

[40]  R. Tsien,et al.  Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts , 1983, Nature.

[41]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[42]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[43]  R. Serrano,et al.  Increased pH and tumorigenicity of fibroblasts expressing a yeast proton pump , 1988, Nature.

[44]  T. Crook,et al.  The p53 pathway in breast cancer , 2002, Breast Cancer Research.

[45]  S. Eschrich,et al.  The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis , 2008, BMC Medical Genomics.

[46]  J. Locker,et al.  Loss of retinal cadherin facilitates mammary tumor progression and metastasis. , 2009, Cancer research.

[47]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[48]  E. Fearon,et al.  The SLUG zinc-finger protein represses E-cadherin in breast cancer. , 2002, Cancer research.

[49]  K. Sossey-Alaoui,et al.  CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer , 2004, Oncogene.

[50]  H. Ishwaran,et al.  Lung metastasis genes couple breast tumor size and metastatic spread , 2007, Proceedings of the National Academy of Sciences.

[51]  Gema Moreno-Bueno,et al.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.

[52]  Krishna Rao,et al.  Loss of RAB25 expression in breast cancer , 2006, International journal of cancer.

[53]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[54]  Jeffrey M. Rosen,et al.  Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[55]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[56]  Archana Dhasarathy,et al.  The Transcription Factor Snail Mediates Epithelial to Mesenchymal Transitions by Repression of Estrogen Receptor - , 2007 .